Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Huvudupphovsman: | Tabassum, Nadira |
---|---|
Övriga upphovsmän: | Yasmin, Hasina |
Materialtyp: | Lärdomsprov |
Språk: | English |
Publicerad: |
Brac University
2024
|
Ämnen: | |
Länkar: | http://hdl.handle.net/10361/22868 |
Liknande verk
-
Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
av: Karmaker, Swastika
Publicerad: (2024) -
Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
av: Mahee, Sadique Abdal
Publicerad: (2024) -
A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
av: Shehab, Habibul Mohsin
Publicerad: (2024) -
A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
av: Jahan, Nusrat
Publicerad: (2023) -
A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
av: Bakar, Osama Bin Abu
Publicerad: (2024)